Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 2,985.00
-15.00 (-0.50%)
Last updated: Oct 30, 2025, 12:19 PM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 234.42 billion as of October 30, 2025. Its market cap has decreased by -35.94% in one year.
Market Cap
234.42B
Enterprise Value
324.30B
Revenue
12.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,985.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 234.42B, a decrease of -61.77%. That is a compound annual growth rate of -18.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 234.42B | -40.51% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 647.62T |
| SK hynix | 359.70T |
| LG Energy Solution | 119.34T |
| Samsung Biologics | 87.69T |
| Doosan Enerbility | 55.34T |
| Hyundai Motor Company | 54.66T |
| HD Hyundai Heavy Industries | 52.73T |
| Hanwha Aerospace | 51.24T |